MADISON,
Wis., Oct. 15, 2024 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced that, effective as of today,
Suzanne Winter has returned from her
temporary medical leave and assumed her full duties as President
and Chief Executive Officer. Sandeep
Chalke, who has served as interim CEO during Ms. Winter's
absence, will continue in his position as Senior Vice President and
Chief Commercial Officer.
"On behalf of the entire Board of Directors, I am delighted
Suzanne has resumed her role as CEO. We appreciate the leadership
provided by Sandeep in her absence and the support of the global
Accuray team," said Joseph Whitters,
Chairman of the Board at Accuray.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions designed to deliver radiation
treatments for even the most complex cases—while making commonly
treatable cases even easier—to meet the full spectrum of patient
needs. We are dedicated to continuous innovation in radiation
therapy for oncology, neuro-radiosurgery, and beyond, as we partner
with clinicians and administrators, empowering them to help
patients get back to their lives, faster. Accuray is headquartered
in Madison, Wisconsin, with
facilities worldwide. To learn more, visit www.accuray.com or
follow us on Facebook, LinkedIn, X, and YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-president-and-chief-executive-officer-suzanne-winter-returns-from-medical-leave-of-absence-302276241.html
SOURCE Accuray Incorporated